Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
Company

Hunan Jingfeng Pharmaceutical gets U.S. FDA approval, qualified to sell prednisone tablets

December 07, 2018


Abstract : Hunan Jingfeng Pharmaceutical (000908.SZ) announced Thursday that it had received approval from the U.S. Food and Drug Administration (FDA) for its prednisone tablet ANDA application.

jingfeng

BEIJING, Dec. 7 (Xinhua) -- Hunan Jingfeng Pharmaceutical Co., Ltd. (000908.SZ) announced Thursday that it had received approval from the U.S. Food and Drug Administration (FDA) for its prednisone tablet ANDA application.

The approval qualifies the company to sell prednisone tablets in the U.S. market which could help it expand overseas market and positively affect its performance, according to a filing with the Shenzhen Stock Exchange.

It is noted that the application was filed by GeneYork Pharmaceuticals Group LLC, a joint venture between its subsidiary Sungen Pharma, LLC and Tianjin Kingyork Group Co., Ltd.

Prednisone tablet sales totaled approximately 139 million U.S. dollars, 134 million U.S. dollars, and 139 million U.S. dollars in the U.S. market in 2015-2017, respectively, according to data service provider IMS. (Edited by Niu Huizhe, niuhuizhe@xinhua.org)

Scan the QR code and push it to your mobile phone

Keyword: China-medical Pharmaceutical Jingfeng FDA

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial